The Lorvotuzumab Biosimilar Anti-CD56 Antibody offered by Assay Genie is a powerful tool for researchers working in the field of oncology. This monoclonal antibody targets the CD56 protein, which is highly expressed on natural killer cells and certain neural tumors. By binding to CD56, this antibody enables precise detection and analysis of CD56-positive cells, making it invaluable for studying cancer progression and therapeutic development.With its high specificity and sensitivity, this antibody is ideal for use in techniques such as immunohistochemistry, flow cytometry, and immunofluorescence. Its versatility allows for a wide range of applications, from basic research to clinical diagnostics.
As CD56 is a well-established marker for certain types of cancer, this antibody can help researchers better understand tumor heterogeneity, monitor disease progression, and evaluate treatment responses.Overall, the Lorvotuzumab Biosimilar Anti-CD56 Antibody from Assay Genie is a reliable and effective reagent for studying CD56-expressing cells in cancer biology. Its quality and performance make it a valuable asset for advancing our knowledge of cancer and developing innovative therapies for patients in need.
Product Name:
Lorvotuzumab (Anti-CD56) Biosimilar Antibody
Size:
100 ug
Product SKU:
HDBS0090
Target:
CD56
Host Species:
Humanized
Reactivity:
Human
Recommended Dilution:
ELISA 1:5000-10000; Flow Cyt 1:100
Antibody Type:
Monoclonal
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Storage & Shipping:
Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing).Lyophilized antibodies are shipped at ambient temperature.
Common Name:
BB-10901, IMGN901, huN901-DM1
Description:
Anti-CD56(lorvotuzumab biosimilar) mAb
Buffer:
Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8% trehalose is added as protectants before lyophilization. Please see Certificate of Analysis for specific instructions.
Format:
Powder
Applications
ELISA, Flow Cyt
Antibody Isotype:
IgG1
Guarantee:
12 months from date of dispatch
Background:
Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.
